Putnam Investments LLC 2seventy Bio, Inc. Transaction History

Putnam Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.14 - $11.2 $103,114 - $367,796	32,839 Added 81.94%	72,917 $285,000
Q2 2023 Aug 14, 2023	BUY	$8.45 - $12.48 $23,617 - $34,881	2,795 Added 7.5%	40,078 $405,000
Q1 2023 May 22, 2023	BUY	$9.21 - $14.98 $140,148 - $227,950	15,217 Added 68.96%	37,283 $380,000
Q4 2022 Feb 14, 2023	SELL	$8.57 - $17.0 $40,047 - $79,441	-4,673 Reduced 17.48%	22,066 $206,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $17.54 $335,841 - $469,002	26,739 New	26,739 $389,000
Q1 2022 May 16, 2022	SELL	$11.67 - $26.72 $229,268 - $524,941	-19,646 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$13.77 - $42.56 $270,525 - $836,133	19,646 New	19,646 $503,000

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $137M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.